Compare LINK & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LINK | IOBT |
|---|---|---|
| Founded | 1984 | 2014 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.5M | 57.2M |
| IPO Year | N/A | 2021 |
| Metric | LINK | IOBT |
|---|---|---|
| Price | $3.85 | $0.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $8.67 | $3.50 |
| AVG Volume (30 Days) | 51.3K | ★ 670.0K |
| Earning Date | 11-12-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $12,023,000.00 | N/A |
| Revenue This Year | $8.30 | N/A |
| Revenue Next Year | $34.68 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.99 | $0.32 |
| 52 Week High | $10.10 | $2.79 |
| Indicator | LINK | IOBT |
|---|---|---|
| Relative Strength Index (RSI) | 48.88 | 36.34 |
| Support Level | $3.70 | $0.50 |
| Resistance Level | $3.98 | $0.55 |
| Average True Range (ATR) | 0.25 | 0.06 |
| MACD | 0.06 | -0.01 |
| Stochastic Oscillator | 62.93 | 2.75 |
Interlink Electronics Inc is a sensor and printed electronics company operating in two principal sensor technology divisions: force/touch sensors, and gas and environmental sensors. It designs, develops, manufactures and sells a range of force-sensing and gas-sensing technologies that incorporate its proprietary materials technology, firmware and software into a portfolio of standard sensor-based products and custom sensor system solutions. Its force-sensing products and solutions include sensor components, subassemblies, modules products that support effective, efficient cursor control and novel three-dimensional user inputs. Its Human Machine Interface technology platforms are deployed in a wide range of markets including consumer electronics, automotive, industrial, and medical.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.